Horizon Diagnostics supports QIAGEN therascreen and ipsogen Customers
For laboratories looking to setup these assays or are already running these assays,... (more)
Publication: Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations.
Abstract Background: Somatic mutation analysis is standard of practice for solid... (more)
Horizon Discovery and LGC Awarded Technology Strategy Board Grant to Develop Standardization for Next Generation Cancer Diagnostics
Improving minimally invasive circulating DNA diagnostic assays supports implementation... (more)
Horizon Discovery and Transgenomic Announce Collaboration for Validation Control and Development of Genetic Diagnostic Tests
Transgenomic will use Horizon’s genetically defined reference standards in... (more)
Katie Odgaard, Zyme Communications Ltd.
Tel: +44 (0) 7787 502 947 Email: email@example.com
Paragraph explaining benefits of Biocair×